Relevant bibliographies by topics / Dysgueusia

Contents

  1. Journal articles
  2. Dissertations / Theses

Academic literature on the topic 'Dysgueusia'

Author: Grafiati
Published: 9 November 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dysgueusia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dysgueusia"

1

Gouel, Pierrick, Clémence Mahana iti Gatti, Luc de Haro, Alice Liautaud, Jérôme Langrand, and Denis Boucaud-Maitre. "Tetrodotoxin Poisoning in Mainland France and French Overseas Territories: A Review of Published and Unpublished Cases." Toxins 14, no. 5 (2022): 351. http://dx.doi.org/10.3390/toxins14050351.

Full text
Abstract:
Tetrodotoxin is one of the most potent neurotoxins in the aquatic world. This review of published and unpublished reports aims to describe the poisoning cases that have occurred in mainland France and overseas territories. Six articles were included, with 13 poisoning events, individuals or collective (number (n) = 53 patients). Moreover, 13 unpublished poisoning events from toxicovigilance networks were found (n = 17). All cases happened in overseas territories: French Guyana (n = 7), New Caledonia (n = 11), Reunion (n = 35) and French Polynesia (n = 17). The median age was 36 years. The most
APA, Harvard, Vancouver, ISO, and other styles
2

Doutrelant, Philippe, Nicolas Penel, Charlotte Renaudat, et al. "Very low seroprevalence of sars-cov-2 among health care personnel (HCP) in a French northern comprehensive cancer center at the end of first national containment." Journal of Clinical Oncology 39, no. 15_suppl (2021): e13604-e13604. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e13604.

Full text
Abstract:
e13604 Background: To limit SARS-Co-2 transmission in general population, French government had set up a first National containment from March 16, 2020 to June 2, 2020. Furthermore, General Direction of our hospital have implemented and organized physical distancing (telework, teleconsultation, virtual multi-disciplinary board), mask wearing, use of alcoholic ... to limit interpersonal contacts. To assess the impact of this policy, we have carried out a seroprevalence study and identified risk factors for SARS-Co-2 prevalence among HCP in May/June 2020. Methods: This is part of CORSER Study (“
APA, Harvard, Vancouver, ISO, and other styles
3

Fleming, Mark T., Dana E. Rathkopf, Jackie Gibbons, et al. "Results from a phase I study of enzalutamide in combination with docetaxel in men with prostate cancer." Journal of Clinical Oncology 31, no. 15_suppl (2013): 5066. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5066.

Full text
Abstract:
5066 Background: Enzalutamide (ENZA) is a novel androgen receptor (AR) inhibitor that prolongs survival in men with metastatic castration-resistant prostate cancer (mCRPC) who had received prior docetaxel (DOC). DOC also prolongs survival in mCRPC and also appears to have anti-tumor effects mediated through the androgen-receptor axis, providing a compelling rationale for combining the two agents. CYP3A4 plays a role in DOC clearance and is induced by ENZA. We therefore conducted a phase I study to explore the PK and safety profiles of this combination. Methods: This study (NCT01565928) evaluat
APA, Harvard, Vancouver, ISO, and other styles
4

Fleming, Mark T., Dana E. Rathkopf, Jackie Gibbons, et al. "Enzalutamide in combination with docetaxel in men with prostate cancer (PC): Preliminary results from a phase I study." Journal of Clinical Oncology 31, no. 6_suppl (2013): 63. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.63.

Full text
Abstract:
63 Background: Enzalutamide (ENZA), a novel oral androgen receptor (AR) inhibitor, inhibits AR signaling via inhibition of androgen binding to the AR, AR nuclear translocation, and nuclear AR-DNA binding. ENZA demonstrated a survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC) who had received prior docetaxel (Scher et al, NEJM 2012; 367:1187). A Phase III study in men with progressive chemotherapy-naïve disease (PREVAIL), is ongoing. Docetaxel (DOC) is the current standard first-line chemotherapy for mCRPC. CYP3A4, which plays a role in DOC clearance, is induce
APA, Harvard, Vancouver, ISO, and other styles
5

Boulinguez, S., M. Mularcyk, and R. Viraben. "Dysgueusie amère aux pignons de pin." Annales de Dermatologie et de Vénéréologie 141, no. 3 (2014): 220–22. http://dx.doi.org/10.1016/j.annder.2014.01.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Aynaou, H., F. M. O. Elilie, and H. Latrech. "Hyperparathyroïdie primaire et dysgueusie : une association inhabituelle." Annales d'Endocrinologie 77, no. 4 (2016): 442–43. http://dx.doi.org/10.1016/j.ando.2016.07.556.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Roblot, P., M. Paccalin, F. Roy-Péaud, C. Landron, L. Juhel, and B. Becq-Giraudon. "Les dysgueusies acquises : après la iatrogénie…" La Revue de Médecine Interne 22 (June 2001): 72–73. http://dx.doi.org/10.1016/s0248-8663(01)83426-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ruhin-Poncet, B., A. Guerre, P. Goudot, and C. Escande. "Dysosmies et dysgueusies post-traumatiques : aspects médicolégaux." Revue de Stomatologie et de Chirurgie Maxillo-faciale 111, no. 5-6 (2010): 296–98. http://dx.doi.org/10.1016/j.stomax.2010.10.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gutiérrez-Cid, Isabel, Arthur Lionnet, and Yann Péréon. "Dysphonie et dysgueusie aiguës : l’ENMG reste un élément clé du diagnostic." Neurophysiologie Clinique/Clinical Neurophysiology 46, no. 3 (2016): 225. http://dx.doi.org/10.1016/j.neucli.2016.06.020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cabon, M., G. Cinquetti, C. Cuvelier, et al. "Une carence de mauvais goût : à propos d’une dysgueusie révélatrice d’une carence martiale." La Revue de Médecine Interne 33 (June 2012): S96—S97. http://dx.doi.org/10.1016/j.revmed.2012.03.128.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Dysgueusia"

1

Buiret, Guillaume. "TORquegueusie avant, pendant et après traitement d’un Cancer des voies AéroDigestives supérieures : étiologies, impact sur la qualité de vie (TORCAD)." Electronic Thesis or Diss., Bourgogne Franche-Comté, 2024. http://www.theses.fr/2024UBFCI009.

Full text
Abstract:
Contexte : Le goût métallique est fréquemment rapporté par les patients au cours de leur traitement d’un cancer des voies aérodigestives supérieures. Très peu d’éléments sont connus sur ce symptôme : quelle est sa fréquence ? Ses cause(s) ?Nous avons mené une étude prospective observationnelle afin d’en déterminer l’incidence et la ou les causes, potentiellement possibles d’après la littérature. Deux hypothèses étaient possibles : une lipopéroxydation au niveau de la muqueuse orale et la levée d’inhibition du nerf facial sur le nerf glossopharyngien.Méthodes : 44 patients ont été suivis avant
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Dysgueusia' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography